Universal flu vaccines: a shot at lifelong cardioprotection?

被引：0
作者：
Bahar Behrouzi
Jacob A. Udell
机构：
[1] Women’s College Hospital,Cardiovascular Division, Department of Medicine
[2] University of Toronto,Institute of Health Policy, Management, and Evaluation, Temerty Faculty of Medicine
[3] ICES,Peter Munk Cardiac Centre
[4] University Health Network,undefined
来源：
Nature Reviews Cardiology | 2022年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Meta-analyses and cardiovascular outcome trials are laying the foundation for seasonal influenza vaccines to be a mainstay in the prevention of cardiovascular disease, rivalling established measures such as statin therapy. In this Clinical Outlook, we highlight current and future approaches for the use of influenza vaccination to reduce the risk of atherosclerotic cardiovascular disease and heart failure.
引用
收藏
页码：145 / 146
页数：1
相关论文
共 11 条
  • [1] Udell JA(2013)Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis J. Am. Med. Assoc. 310 1711-1720
  • [2] Yedlapati SH(2021)Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: a systematic review and meta-analysis J. Am. Heart Assoc. 10 1476-1484
  • [3] Fröbert O(2021)Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial Circulation 144 39-49
  • [4] Vardeny O(2021)Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular disease: a randomized clinical trial J. Am. Med. Assoc. 325 54-61
  • [5] Hollingsworth R(2021)Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: rationale and design of a real-world pragmatic randomized clinical trial Am. Heart J. 237 36-44
  • [6] Loeb M(2019)Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): rationale and design Am. Heart J. 212 1485-1488
  • [7] Michos ED(2021)Am I getting the influenza shot too? Influenza vaccination as post-myocardial infarction care for the prevention of cardiovascular events and death Circulation 144 1777-1794
  • [8] Udell JA(2020)Influenza vaccination to reduce cardiovascular morbidity and mortality in patients with COVID-19: J. Am. Coll. Cardiol. 76 106-114
  • [9] Behrouzi B(2021) state-of-the art review Nat. Med. 27 801-803
  • [10] Nachbagauer R(2021)A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial Nat. Rev. Drug Discov. 20 undefined-undefined
12